Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Lowered to “Sell” Rating by Wall Street Zen

Wall Street Zen lowered shares of Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) from a hold rating to a sell rating in a report released on Saturday.

Separately, Weiss Ratings assumed coverage on shares of Inspira Technologies OXY B.H.N. in a report on Wednesday, May 27th. They set a “sell (e+)” rating for the company. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Inspira Technologies OXY B.H.N. Trading Down 0.9%

NASDAQ:QTEX opened at $1.05 on Friday. Inspira Technologies OXY B.H.N. has a 1 year low of $0.28 and a 1 year high of $3.85. The firm has a fifty day moving average price of $1.49. The company has a current ratio of 1.56, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08.

Inspira Technologies OXY B.H.N. announced that its board has authorized a stock repurchase plan on Monday, June 22nd that allows the company to repurchase 2,000,000,000,000 shares. This repurchase authorization allows the company to repurchase up to 5.6% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.